BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10959646)

  • 21. Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104.
    Preußel K; Höhle M; Stark K; Werber D
    PLoS One; 2013; 8(11):e78180. PubMed ID: 24244292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.
    Brandal LT; Wester AL; Lange H; Løbersli I; Lindstedt BA; Vold L; Kapperud G
    BMC Infect Dis; 2015 Aug; 15():324. PubMed ID: 26259588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.
    Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE
    Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.
    Melli LJ; Ciocchini AE; Caillava AJ; Vozza N; Chinen I; Rivas M; Feldman MF; Ugalde JE; Comerci DJ
    J Clin Microbiol; 2015 Feb; 53(2):528-38. PubMed ID: 25472487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli.
    Paton AW; Ratcliff RM; Doyle RM; Seymour-Murray J; Davos D; Lanser JA; Paton JC
    J Clin Microbiol; 1996 Jul; 34(7):1622-7. PubMed ID: 8784557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrogation of single nucleotide polymorphisms in gnd provides a novel method for molecular serogrouping of clinically important Shiga toxin producing Escherichia coli (STEC) targeted by regulation in the United States, including the "big six" non-O157 STEC and STEC O157.
    Elder JR; Bugarel M; den Bakker HC; Loneragan GH; Nightingale KK
    J Microbiol Methods; 2016 Oct; 129():85-93. PubMed ID: 27432340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Value of Serological Tests Against Verotoxigenic Escherichia coli in Hemolytic Uremic Syndrome in Children.
    Leszczyńska B; Ziółkowska H; Podsiadły E; Szych J; Rastawicki W; Demkow U; Roszkowska-Blaim M
    Adv Clin Exp Med; 2015; 24(6):1031-6. PubMed ID: 26771976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shiga toxin-producing Escherichia coli O171:H25 strain isolated from a patient with haemolytic uraemic syndrome.
    Lepšanović Z; Opačić D; Lazić S; Herpay M; Tóth S; Kostić M; Kucsera I
    Acta Microbiol Immunol Hung; 2012 Jun; 59(2):215-24. PubMed ID: 22750781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria.
    Verweyen HM; Karch H; Allerberger F; Zimmerhackl LB
    Infection; 1999; 27(6):341-7. PubMed ID: 10624594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking verocytotoxigenic Escherichia coli O157, O26, O111, O103 and O145 in Irish cattle.
    Thomas KM; McCann MS; Collery MM; Logan A; Whyte P; McDowell DA; Duffy G
    Int J Food Microbiol; 2012 Feb; 153(3):288-96. PubMed ID: 22209630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H- causes another outbreak of haemolytic uraemic syndrome in children.
    Alpers K; Werber D; Frank C; Koch J; Friedrich AW; Karch H; An DER Heiden M; Prager R; Fruth A; Bielaszewska M; Morlock G; Heissenhuber A; Diedler A; Gerber A; Ammon A
    Epidemiol Infect; 2009 Mar; 137(3):389-95. PubMed ID: 19021923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.
    van de Kar NC; Roelofs HG; Muytjens HL; Tolboom JJ; Roth B; Proesmans W; Reitsma-Bierens WC; Wolff ED; Karmali MA; Chart H; Monnens LA
    Eur J Pediatr; 1996 Jul; 155(7):592-5. PubMed ID: 8831084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland.
    Nüesch-Inderbinen M; Morach M; Cernela N; Althaus D; Jost M; Mäusezahl M; Bloomberg G; Stephan R
    Int J Med Microbiol; 2018 Oct; 308(7):933-939. PubMed ID: 30042042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological analysis of a large enterohaemorrhagic Escherichia coli O111 outbreak in Japan associated with haemolytic uraemic syndrome and acute encephalopathy.
    Yahata Y; Misaki T; Ishida Y; Nagira M; Watahiki M; Isobe J; Terajima J; Iyoda S; Mitobe J; Ohnishi M; Sata T; Taniguchi K; Tada Y; Okabe N;
    Epidemiol Infect; 2015 Oct; 143(13):2721-32. PubMed ID: 25600435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome.
    Schmidt H; Karch H
    J Clin Microbiol; 1996 Oct; 34(10):2364-7. PubMed ID: 8880480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal diagnostics in combination with serology: best test to establish STEC-HUS.
    Wijnsma KL; van Bommel SA; van der Velden T; Volokhina E; Schreuder MF; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2016 Nov; 31(11):2163-70. PubMed ID: 27240858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.